U.S. Loses Ground On Biomedical R&D

The U.S. continues to dominate the world in biomedical research spending, but its share of the total spending pie slipped from 50% in 2007 to 45% in 2012, according to a new report. Europe’s share also slipped over the same period. Meanwhile, China more than quadrupled its share, although it still accounted for only 3% of the global R&D spend.

The study, published in the New England Journal of Medicine, attributes the U.S. decline to . . .